Current immunological approaches for management of allergic rhinitis and bronchial asthma

Inflammation Research

Volumn 58, Issue 9, 2009, Pages 523-536

  Srivastava, Deepsikha ^a   Arora, Naveen ^a   Singh, Bhanu Pratap ^a  

^a CSIR INSTITUTE OF GENOMICS AND INTEGRATIVE BIOLOGY   (India)

Author keywords

Allergen; Asthma; CD4+; IgE; IgG; Rhinitis; Specific immunotherapy; T cell anergy; TH1; TH2

Indexed keywords

ADJUVANT; ALLERGEN; ALLERGOID DERIVATIVE; COMPLEMENTARY DNA; CYTOKINE; DNA; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INTERLEUKIN 18; INTERLEUKIN 4 ANTIBODY; INTERLEUKIN 4 RECEPTOR ALPHA; INTERLEUKIN 5; INTERLEUKIN 5 ANTIBODY; LIPOSOME; MONOCLONAL ANTIBODY; OMALIZUMAB; PEPTIDE DERIVATIVE; RECOMBINANT ALLERGEN; RECOMBINANT INTERLEUKIN 12; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9; UNCLASSIFIED DRUG; VACCINE; VIRUS DNA;

ALLERGIC RHINITIS; ANAPHYLAXIS; ASTHMA; CD4+ T LYMPHOCYTE; CLINICAL FEATURE; CPG ISLAND; DISEASE SEVERITY; DNA SEQUENCE; DOSE RESPONSE; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; HUMAN; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOTHERAPY; INTESTINAL BLEEDING; NASAL PRURITUS; NONHUMAN; REVIEW; RHINITIS; RISK FACTOR; SIGNAL TRANSDUCTION; TREATMENT DURATION;

ALLERGENS; ANIMALS; ANTI-ASTHMATIC AGENTS; ASTHMA; CLINICAL TRIALS AS TOPIC; CYTOKINES; DESENSITIZATION, IMMUNOLOGIC; HUMANS; IMMUNOGLOBULIN E; RHINITIS, ALLERGIC, PERENNIAL;

EID: 68449085744     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-009-0033-7     Document Type: Review

References (161)

1. M Akdis J Verhagen A Taylor 2004 Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells J Exp Med 199 1567 1575
2. SJ Galli M Tsai AM Piliponsky 2008 The development of allergic inflammation Nature 454 445 454
3. R Lund H Ahlfors E Kainonen AM Lahesmaa C Dixon R Lahesmaa 2005 Identification of genes involved in the initiation of human Th1 or Th2 cell commitment Eur J Immunol 35 3307 3319
4. H2 cells Curr Opin Hematol 8 47 51
5. J Tavakkol Afshari R Farid Hosseini S Hosseini Farahabadi 2007 Association of the expression of IL-4 and IL-13 genes, IL-4 and IgE serum levels with allergic asthma Iran J Allergy Asthma Immunol. 6 67 72
6. RJ Salib A Drake-Lee PH Howarth 2003 Allergic rhinitis: past, present and the future Clin Otolaryngol Allied Sci 28 291 303
7. SN Gaur S Rajpal A Rohatgi 2004 Prevalence of bronchial asthma and allergic rhinitis among school children in Delhi Intern Med J Thai. 20 8 13
8. SK Chhabra CK Gupta P Chhabra S Rajpal 1998 Prevalence of bronchial asthma in schoolchildren in Delhi J Asthma 35 291 296
9. R Vishwanathan 1964 Definition, incidence, etiology and natural history of asthma Ind J Chest Dis. 6 108 124
10. R Ariano P Berto D Tracci C Incorvaia F Frati 2006 Pharmacoeconomics of allergen immunotherapy compared with symptomatic drug treatment in patients with allergic rhinitis and asthma Allergy Asthma Proc. 27 159 163
11. M Chan-Yeung H Dimich-Ward A Becker 2007 Atopy in early life and effect of a primary prevention program for asthma in a high-risk cohort J Allergy Clin Immunol. 120 1221 1223
12. AB Tonnel 2005 Specific immunotherapy and therapeutic strategies in allergic diseases. What's new? Bull Acad Natl Med. 189 1475 1487
13. C Moller S Dreborg HA Ferdousi 2002 Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis J Allergy Clin Immunol. 109 251 256
14. NF Adkinson Jr PA Eggleston D Eney 1997 A controlled trial of immunotherapy for asthma in allergic children N Engl J Med 336 324 331
15. K Dam Petersen D Gyrd-Hansen S Kjaergaard R Dahl 2005 Clinical and patient based evaluation of immunotherapy for grass pollen and mite allergy Allergol Immunopathol (Madr). 33 264 269 (Pubitemid 41769445)
16. G Casimir P Cuvelier S Allard J Duchateau 1997 Life-threatening fish allergy successfully treated with immunotherapy Pediatr Allergy Immunol 8 103 105
17. SN Gaur S Gupta 1996 Clinical response of immunotherapy in cases of nasobronchial allergy Indian J Allergy Appl Immunol. 10 65 68
18. PR Karmakar A Das BP Chatterjee 1994 Placebo-controlled immunotherapy with Cocos nucifera pollen extract Int Arch Allergy Immunol 103 194 201
19. WA Sheikh 1997 Immunotherapy vs. inhaled budesonide in bronchial asthma: an open, parallel, comparative trial Clin Exp Allergy 27 1279 1284
20. D Srivastava BP Singh VT Sudha N Arora SN Gaur 2007 Immunotherapy with mosquito (Culex quinquefasciatus) extract: a double-blind, placebo-controlled study Ann Allergy Asthma Immunol 99 273 280
21. Anonymus (2007) Clinico-immunologic studies on allergen specific immunotherapy in patients of respiratory allergy (2004-2007). Project report Department of Science and Technology, New Delhi.
22. Y Young-Min L Soo-Keol K Seung-Hyun N Dong-Ho S Chang-Hee P Hae-Sim 2006 Changes of serum cytokines after the long-term immunotherapy with Japanese Hop pollen extracts J Korean Med Sci 21 805 810
23. Y Ohashi Y Nakai A Tanaka 1998 Ten-year follow-up study of allergen-specific immunoglobulin E and immunoglobulin G4, soluble interleukin-2 receptor, interleukin-4, soluble intercellular adhesion molecule-1 and soluble vascular cell adhesion molecule-1 in serum of patients on immunotherapy for perennial allergic rhinitis Scand J Immunol 47 167 178 (Pubitemid 28122800)
24. GB Pajno G Barberio F De Luca L Morabito S Parmiani 2001 Prevention of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy. A six-year follow-up study Clin Exp Allergy. 31 1392 1397
25. F Marcucci L Sensi G Allocca 2007 Sublingual immunotherapy: from safety to mechanism of action Eur Ann Allergy Clin Immunol. 39 101 103
26. M Di Gioacchino A Perrone C Petrarca 2008 Early cytokine modulation after the rapid induction phase of sublingual immunotherapy with mite monomeric allergoids Int J Immunopathol Pharmacol. 21 969 976
27. J Savolainen L Jacobsen E Valovirta 2006 Sublingual immunotherapy in children modulates allergen-induced in vitro expression of cytokine mRNA in PBMC Allergy 61 1184 1190
28. CA Akdis IB Barlan N Bahceciler M Akdis 2006 Immunological mechanisms of sublingual immunotherapy Allergy S 81 11 14
29. C Antunez C Mayorga JL Corzo A Jurado MJ Torres 2008 Two year follow-up of immunological response in mite-allergic children treated with sublingual immunotherapy. Comparison with subcutaneous administration Pediatr Allergy Immunol 19 210 218
30. M Silvestri D Spallarosa E Battistini 2002 Changes in inflammatory and clinical parameters and in bronchial hyperreactivity asthmatic children sensitized to house dust mites following sublingual immunotherapy J Investig Allergol Clin Immunol 12 52 59
31. B Mortemousque F Bertel J De Casamayor P Verin J Colin 2003 House dust mite sublingual swallow immunotherapy in perennial conjunctivitis: a double blind placebo controlled study Clin Exp Allergy 33 464 469
32. JB Sun N Cuburu M Blomquist BL Li C Czerkinsky J Holmgren 2006 Sublingual tolerance induction with antigen conjugated to cholera toxin B subunit induces Foxp3+ CD25+ CD4+ regulatory T cells and suppresses delayed-type hypersensitivity reactions Scand J Immunol 64 251 259 (Pubitemid 44215115)
33. M Bagnasco G Mariani G Passalacqua 1997 Absorption and distribution kinetics of the major Parietaria judaica allergen (Par j 1) administered by noninjectable routes in healthy human beings J Allergy Clin Immunol. 100 122 129
34. C Moller S Dreborg A Lanner B Bjorksten 1986 Oral immunotherapy of children with rhinoconjuctivitis due to birch pollen allergy Allergy 41 271 277
35. A Giovane M Bardare G Passalacqua 1994 A three year double blind placebo controlled study with oral immunotherapy to pediatric patients Clin Exp Allergy 24 53 59
36. A Miller O Lider AB Roberts MB Sporn HL Weiner 1992 Suppressor T cells generated by oral tolerance to myelin basic protein suppress both in vitro and in vivo immune response by release of TGF β following antigen specific triggering Proc Nal Acad Sci USA. 89 421 425
37. H Mosbech S Dreberg F Madsenn 1987 High dose grass pollen tablets used for hyposensitization in hay fever patients. A 1 year double blind placebo controlled study Allergy 42 451 455
38. A Litwin M Flanazan G Eritis 1997 Oral immunotherapy with short ragweed in a novel encapsulated preparation: a double blind study J Allergy Clin Immunol. 100 30 38
39. MG Tari M Mancino G Monti 1992 Immunotherapy by inhalation of allergen in powder in house dust allergic asthma: a double blind study J Invest Allergol Clin Immunol. 2 59 67
40. MJ Schumacher MC Pain 1982 Intranasal immunotherapy with polymerized grass pollen allergens Allergy 37 241 248
41. MH Loveless 1940 Immunological studies of pollinosis: I. The presence of two antibodies related to the same pollen antigen in the serum of treated hay-fever patients J Immunol 38 25 50
42. C Pilette KT Nouri-Aria MR Jacobson 2007 Grass pollen immunotherapy induces an allergen-specific IgA2 antibody response associated with mucosal TGF-β expression J Immunol 178 4658 4666
43. S Flicker P Steinberger L Norderhaug 2002 Conversion of grass pollen allergen specific human IgE into a protective IgG1 antibody Eur J Immunol 32 2156 2162
44. A Kawakami R Koketsu M Suzukawa 2008 Blocking antibody is generated in allergic rhinitis patients during specific immunotherapy using standardized Japanese cedar pollen extract Int Arch Allergy Immunol 146 S1 54 60
45. N Rabinovitch EW Gelfand 2004 Expression of functional activating and inhibitory Fcgamma receptors on human B cells Int Arch Allergy Immunol 133 285 294
46. M Larche CA Akdis R Valenta 2006 Immunological mechanisms of allergen-specific immunotherapy Nat Rev Immunol 6 761 771
47. PA Wachholz NK Soni SJ Till SR Durham 2003 Inhibition of allergen-IgE binding to B cells by IgG antibodies after grass pollen immunotherapy J Allergy Clin Immunol. 112 915 922
48. Q Zhuang S Bisotto ED Fixman B Mazer 2002 Suppression of IL-4- and CD40-induced B-lymphocyte activation by intravenous immunoglobulin is not mediated through the inhibitory IgG receptor FcgammaRIIb J Allergy Clin Immunol. 110 480 483
49. P Jeannin Y Delneste I Tillie-Leblond 1994 Abnormal IgG4 antibody response to aeroallergens in allergic patients Int Arch Allergy Immunol 104 191 198
50. T Ball WR Sperr P Valent 1999 Induction of antibody responses to new B-cell epitopes indicates vaccination character of allergen immunotherapy Eur J Immunol 29 2026 2036
51. SR Durham SM Walker EM Varga 1999 Long-term clinical efficacy of grass pollen immunotherapy N Engl J Med 341 468 475
52. M Akdis CA Akdis 2007 Mechanisms of allergen-specific immunotherapy J Allergy Clin Immunol. 119 780 789
53. RJ Van Neerven T Wikborg G Lund 1999 Blocking antibodies induced by specific allergy vaccination prevents the activation of CD4+ T cells by inhibiting serum-IgE-facilitated allergen presentation J Immunol 163 2944 2952
54. H1 dominant pattern: comparison of rush and conventional immunotherapy Clin Exp Allergy 25 828 833
55. LM Gardner FC Thien JA Douglass JM Rolland RE O'Hehir 2004 Induction of T regulatory cells by standardized house dust mite immunotherapy: an increase in CD4+ CD25+ interleukin-10+ T cells expressing peripheral tissue trafficking markers Clin Exp Allergy 34 1209 1219
56. K Presser D Schwinge M Wegmann 2008 Coexpression of TGF-beta1 and IL-10 enables regulatory T cells to completely suppress airway hyperreactivity J Immunol 181 7751 7758
57. L Borish A Aarons J Rumbyrt P Cvietusa J Negri S Wenzel 1996 Interleukin-10 regulation in normal subjects and patients with asthma J Allergy Clin Immunol. 97 1288 1296
58. H Koning HJ Neijens MR Baert AP Oranje HF Savelkoul 1997 T cells subsets and cytokines in allergic and non-allergic children. II. Analysis and IL-5 and IL-10 mRNA expression and protein production Cytokine 9 427 436 (Pubitemid 27249976)
59. M Jutel M Akdis F Budak 2003 IL-10 and TGF-β cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy Eur J Immunol 33 1205 1214
60. JN Francis SJ Till SR Durham 2003 Induction of IL-10 CD4+ CD25+ T cells by grass pollen immunotherapy J Allergy Clin Immunol. 111 1255 1261
61. L Schandene C Alonso-Vega F Willems 1994 B7/CD28-dependent IL-5 production by human resting T cells is inhibited by IL-10 J Immunol 152 4368 4374
62. CA Akdis A Joss M Akdis A Faith K Blaser 2000 A molecular basis for T cell suppression by IL-10: CD28-associated IL-10 receptor inhibits CD28 tyrosine phosphorylation and phosphatidylinositol. 3-kinase binding FASEB J 14 1666 1668 (Pubitemid 30688612)
63. MJ Abramson RM Puy JM Weiner 2003 Allergen immunotherapy for asthma Cochrane Database Syst Rev. 4 CD001186
64. SH Tseng LS Fu BR Nong JD Weng SD Shyur 2008 Changes in serum specific IgG4 and IgG4/IgE ratio in mite-sensitized Taiwanese children with allergic rhinitis receiving short-term sublingual-swallow immunotherapy: a multicenter, randomized, placebo-controlled trial Asian Pac J Allergy Immunol 26 105 112
65. P Moingeon T Batard R Fadel F Frati J Sieber L Van Overtvelt 2006 Immune mechanisms of allergen-specific sublingual immunotherapy Allergy 61 151 165 (Pubitemid 43381824)
66. B Bohle T Kinaciyan M Gerstmayr A Radakovics B Jahn-Schmid C Ebner 2007 Sublingual immunotherapy induces IL-10-producing T regulatory cells, allergen-specific T-cell tolerance, and immune deviation J Allergy Clin Immunol. 120 707 713
67. L Cosmi V Santarlasci R Angeli 2006 Sublingual immunotherapy with Dermatophagoides monomeric allergoid down-regulates allergen-specific immunoglobulin E and increases both interferon-gamma- and interleukin-10- production Clin Exp Allergy 36 261 272
68. JP Allam N Novak C Fuchs 2003 Characterization of dendritic cells from human oral mucosa: a new Langerhans cell type with high constitutive FcepsilonRI expression J Allergy Clin Immunol. 112 141 148
69. JP Allam B Niederhagen M Bücheler 2006 Comparative analysis of nasal and oral mucosa dendritic cells Allergy 61 166 172
70. MA Rank CL Oslie JL Krogman MA Park JT Li 2008 Allergen immunotherapy safety: characterizing systemic reactions and identifying risk factors Allergy Asthma Proc. 29 400 405
71. M Karaayvaz F Erel Z Caliskaner N Ozanguc 1999 Systemic reactions due to allergen immunotherapy J Investig Allergol Clin Immunol 9 39 44
72. MF Martin Munoz 2004 Efficacy of immunotherapy in the treatment of asthma Allergol Immunopathol 32 133 141
73. EM Gonzalez M Villalba R Rodriguez 2000 Allergenic cross-reactivity of Olive pollen Allergy 55 658 663
74. G Di Felice B Barletta R Tingho C Pini 2001 Cupressaceae pollinosis: identification, purification and cloning of relevant allergens Int Arch Allergy Immunol 125 280 289
75. P Chakraborty S Gupta-Bhattacharya I Roy S Chanda 2004 Identification of shared allergenic components from four common and dominant pollen taxa of Arecaceae Curr Science. 86 1539 1543
76. P Moingeon M Hrabina KC Bergmann 2008 Specific immunotherapy for common grass pollen allergies: pertinence of a five grass pollen vaccine Int Arch Allergy Immunol 146 338 342
77. S Chaudhry S Jhamb UP Chauhan SN Gaur HC Agarwal MK Agarwal 1990 Shared and specific allergenic and antigenic components in the two sexes of American cockroach Periplaneta americana Clin Exp Allergy 20 59 65
78. TJ Grier DM LeFevre EA Duncan RE Esch 2007 Stability of standardized grass, dust mite, cat, and short ragweed allergens after mixing with mold or cockroach extracts Ann Allergy Asthma Immunol 99 151 160
79. G Pauli 2000 Evolution in the understanding of cross-reactivities of respiratory allergens: the role of recombinant allergens Int Arch Allergy Immunol 123 183 195
80. MJ Van der Veen M Mulder AM Witteman R Van Ree RC Aalberse HM Jansen 1996 False-positive skin prick test responses to commercially available dog dander extracts caused by contamination with house dust mite (Dermatophagoides pteronyssinus) allergens J Allergy Clin Immunol. 98 1028 1034
81. BP Singh SV Gangal 2001 Defined allergen extracts; need for efficient diagnosis of allergy and immunotherapy Indian J Allergy Asthma Immunol. 15 67 74
82. VT Sudha D Srivastava N Arora SN Gaur BP Singh 2007 Stability of protease rich Periplaneta americana allergen extracts during storage: formulating preservatives to enhance shelf life J Clin Immunol 27 294 301
83. H Ruiz Reyes AR Rodriguez Orozco 2006 Allergic fungi: importance of the standardization of fungal extracts and their application on clinical practice Rev Alerg Mex 53 144 149
84. KM Bijli BP Singh S Sridhara SN Gaur N Arora 2002 Standardizing Imperata cylindrica source material for quality allergen preparations Immunol Methods. 260 91 96
85. VP Kurup 2003 Fungal allergens Curr Allergy Asthma Rep. 3 416 423
86. V Bisht N Arora BP Singh SN Gaur S Sridhara 2004 Purification and characterization of a major cross-reactive allergen from Epicoccum purpurascens Int Arch Allergy Immunol 133 217 224
87. A Dhyani N Arora SN Gaur VK Jain S Sridhara BP Singh 2006 Analysis of IgE binding proteins of mesquite (Prosopis juliflora) pollen and cross-reactivity with predominant tree pollens Immunobiology. 211 733 740
88. VT Sudha N Arora S Sridhara SN Gaur BP Singh 2006 Biopotency and identification of allergenic proteins in Periplaneta americana extract for clinical applications Biologicals. 35 131 137
89. SP Patil PV Niphadkar MM Bapat 2001 Chickpea: a major food allergen in the Indian subcontinent and its clinical and immunochemical correlation Ann Allergy Asthma Immunol 87 140 145
90. D Kumari R Kumar S Sridhara N Arora SN Gaur BP Singh 2006 Sensitization to black gram in patients with bronchial asthma and rhinitis: clinical evaluation and characterization of allergens Allergy 61 104 110
91. R Kumar P Srivastava D Kumari 2007 Rice (Oryza sativa) allergy in rhinitis and asthma patients: a clinico-immunological study Immunobiology. 212 141 147
92. M Ito T Kato T Matsuda 2005 Rice allergenic proteins, 14-16 kDa albumin and alpha-globulin, remain insoluble in rice grains recovered from rice miso (rice-containing fermented soybean paste) Biosci Biotechnol Biochem 69 1137 1144
93. AM Scurlock AW Burks 2004 Peanut allergenicity Ann Allergy Asthma Immunol 93 S12 S18
94. J Lin PR Shewry DB Archer 2006 Potential allergenicity of two 2S albumins from soybean (Glycine max): a protein microarray approach Int Arch Allergy Immunol 141 91 102
95. H Secrist RH DeKruyff DT Umetsu 1995 Interleukin 4 production by CD4+ cells from allergic individuals is modulated by allergen concentration and antigen-presenting cell type J Exp Med 181 1081 1090
96. KT HayGlass BP Stefura 1991 Anti-interferon gamma treatment blocks the ability of glutaraldehyde-polymerized allergens to inhibit specific IgE responses J Exp Med 173 279 285
97. S Ohman J Bjorkander S Dreborg A Lanner HJ Malling B Weeke 1986 A preliminary study of immunotherapy with a monomethoxy polyethylene glycol modified honey bee venom preparation Allergy 41 81 88 (Pubitemid 16044347)
98. A Malet M Lluch AL Valero M Casanovas 1994 Clinical and immunological effects of immunotherapy with glutaraldehyde modified house dust mite extract Allergol Immunopathol (Madr). 22 226 232
99. KG Pollock M Conacher XQ Wei J Alexander JM Brewer 2003 Interleukin-18 plays a role in both the alum-induced T helper 2 response and the T helper 1 response induced by alum-adsorbed interleukin-12 Immunology 108 137 143
100. N Arora SV Gangal 1992 Efficacy of liposome entrapped allergen in regulation of IgE response in mice Clin Exp Allergy 22 35 42
101. Gangal SV, Arora N, Chugh L, Sehra S, Singh B, Malik BK (1999) Immunomodulation and immunotherapy using liposome entrapped allergens. Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M 93: 267-73
102. H1 responses by liposome entrapped allergen and its potential in immunotherapy of allergic disorders Clin Exp Allergy 28 1530 1537
103. G Cevc D Gebauer J Stieber A Schaltzein G Blume 1998 Ultraflexible vesicles, transfersomes, have an extremely pore penetration resistant and transport therapeutic amount of insulin across the intact mammalian skin Biochim Biophys Acta 1368 201 215
104. MD Chapman AM Smith LD Vailes LK Arruda V Dhanaraj A Pomes 2000 Recombinant allergens for diagnosis and therapy of allergic diseases J Allergy Clin Immunol. 106 409 418
105. J Shankar BP Singh SN Gaur N Arora 2006 Recombinant glutathione-S- transferase, a major allergen from Alternaria alternata for clinical use in allergy patients Mol Immunol 43 1927 1932
106. S Tresch D Holzmann S Baumann 2003 In vitro and in vivo allergenicity of recombinant Bet v 1 compared to the reactivity of natural birch pollen extract Clin Exp Allergy 33 1153 1158
107. M Jutel L Jaeger R Suck H Meyer H Fiebig O Cromwell 2005 Allergen-specific immunotherapy with recombinant grass pollen allergens J Allergy Clin Immunol. 116 608 613
108. G Pauli TH Larsen S Rak 2008 Efficacy of recombinant birch pollen vaccine for the treatment of birch-allergic rhinoconjunctivitis J Allergy Clin Immunol. 122 951 960
109. V Niederberger F Horak S Vrtala 2004 Vaccination with genetically engineered allergens prevents progression of allergic disease Proc Natl Acad Sci USA. 101 14677 14682
110. C Von Garnier M Astori A Kettner 2000 Allergen-derived long peptide immunotherapy down-regulates specific IgE response and protects from anaphylaxis Eur J Immunol 30 1638 1645
111. R Kammerer Y Chvatchko A Kettner N Dufour G Corradin F Spertini 1997 Modulation of T-cell response to phospholipase A2 and phospholipase A2-derived peptides by conventional bee venom immunotherapy J Allergy Clin Immunol. 100 96 103
112. JM Fellrath A Kettner N Dufour 2003 Allergen-specific T-cell tolerance induction with allergen-derived long synthetic peptides: results of a phase I trial J Allergy Clin Immunol. 111 854 861
113. J Pene A Desroches L Paradis 1998 Immunotherapy with Fel d 1 peptides decreases IL-4 release by peripheral blood T cells of patients allergic to cats J Allergy Clin Immunol. 102 571 578
114. U Muller CA Akdis M Fricker 1998 Successful immunotherapy with T-cell epitope peptides of bee venom phospholipase A 2 induces specific T-cell anergy in patients allergic to bee venom J Allergy Clin Immunol. 101 747 754
115. W Oldfield M Larche A Kay 2002 Effect of T cell peptides derived from Fel d 1 on allergic reactions and cytokine production in patients sensitive to cats: a randomized controlled trial Lancet. 360 47 53
116. P Maguire C Nicodemus D Aaronson D Robinson DT Umetsu 1999 The safety and efficacy of ALLERVAX CAT in cat allergic patients Clin Immunol. 93 222 231
117. CA Akdis M Akdis T Blesken 1996 Epitope-specific T cell tolerance to phospholipase A2 in bee venom immunotherapy and recovery by IL-2 and IL-15 in vitro J Clin Invest 98 1676 1683
118. BA Helm AC Spivey EA Padlan 1997 Peptide blocking of IgE/receptors interaction: possibilities and pitfalls Allergy 52 1155 1169
119. C Prussin DT Griffith KM Boesel H Lin B Foster TB Casale 2003 Omalizumab treatment down regulates dendritic cell FcepsilonRI expression J Allergy Clin Immunol. 112 1147 1154
120. MV Kopp J Brauburger F Riedinger 2002 The effect of anti-IgE treatment on in vitro leukotriene release in children with seasonal allergic rhinitis J Allergy Clin Immunol. 110 728 735
121. Djukanovi R, Wilson SJ, Kraft M, Jarjour NN, Steel M, Chung KF et al. Effects of treatment with anti-immunoglobulin E antibody omalizumab on airway inflammation in allergic asthma. Am J Respir Crit Care Med. (2004); 170: 583-93.
122. S Walker M Monteil K Phelan TJ Lasserson EH Walters 2006 Anti-IgE for chronic asthma in adults and children Cochrane Database Syst Rev 19 2 CD003559
123. TB Casale WW Busse JN Kline 2006 Omalizumab pretreatment decreases acute reactions after rush immunotherapy for ragweed-induced seasonal allergic rhinitis J. Allergy Clin Immunol. 117 134 140
124. C Bez R Schubert M Kopp 2004 Effect of anti-immunoglobulin E on nasal inflammation in patients with seasonal allergic rhino conjunctivitis Clin Exp Allergy 34 1079 1085
125. C Rolinck-Werninghaus E Hamelmann T Keil 2004 The co-seasonal application of anti-IgE after preseasonal specific immunotherapy decreases ocular and nasal symptom scores and rescue medication use in grass pollen allergic children Allergy 59 973 979
126. J Kuehr J Brauburger S Zielen 2002 Efficacy of combination treatment with anti-IgE plus specific immunotherapy in polysensitized children and adolescents with seasonal allergic rhinitis J Allergy Clin Immunol. 109 274 280
127. KG Tournoy JC Kips RA Pauwels 2001 The allergen-induced airway hyperresponsiveness in a human-mouse chimera model of asthma is T cell and IL-4 and IL-5 dependent J Immunol 166 6982 6991
128. LC Borish HS Nelson J Corren 2001 Efficacy of soluble IL-4 receptor for the treatment of adults with asthma J Allergy Clin Immunol. 107 963 970
129. LC Borish HS Nelson MJ Lanz 1999 Interleukin-4 receptor in moderate atopic asthma. A phase I/II randomized, placebo-controlled trial Am J Respir Crit Care Med 160 1816 1823
130. JC Kips BJ O'Connor SJ Langley 2003 Effect of SCH55700, a humanized anti-human interleukin-5 antibody, in severe persistent asthma: a pilot study Am J Respir Crit Care Med 167 1655 1659
131. MJ Leckie A ten Brinke J Khan 2000 Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response Lancet. 356 2144 2148
132. HA Boushey JV Fahy 2000 Targeting cytokines in asthma therapy: round one Lancet. 356 2114 2116
133. PT Flood-Page AN Menzies-Gow AB Kay DS Robinson 2003 Eosinophil's role remains uncertain as anti-interleukin-5 only partially depletes numbers in asthmatic airway Am J Respir Crit Care Med 167 199 204
134. T Terada K Zhang J Belperio V Londhe A Saxon 2006 A chimeric human-cat Fcgamma-Fel d 1 fusion protein inhibits systemic, pulmonary and cutaneous allergic reactivity to intratracheal challenge in mice sensitized to Fel d 1, the major cat allergen Clin Immunol. 120 45 56
135. SA Bryan BJ O'Connor S Matti 2000 Effects of recombinant human interleukin-12 on eosinophils, airway hyper-responsiveness, and the late asthmatic response Lancet. 356 2149 2153
136. TS Kim RH DeKruyff R Rupper HT Maecker S Levy DT Umetsu 1997 An ova-IL-12 fusion protein is more effective than OVA plus rIL-12 in inducing a Th1-dominated immune response and inhibiting antigen-specific IgE production J Immunol 158 4137 4144
137. DM Walter CP Wong RH DeKruyff GJ Berry S Levy DT Umetsu 2001 IL-18 gene transfer by adenovirus prevents the development of and reverses established allergen induced airway hyper reactivity J Immunol 166 6392 6398
138. H2-driven allergic immune responses J Immunol 174 1097 1103
139. H2 responses to mite allergen J Allergy Clin Immunol. 117 1148 1154
140. K Takeda S Akira 2005 Toll-like receptors in innate immunity Int Immunol 17 1 14
141. AM Krieg 2006 Therapeutic potential of Toll-like receptor 9 activation Nat Rev Drug Discov. 5 471 484
142. DM Klinman 2004 Immunotherapeutic uses of CpG oligodeoxynucleotides Nat Rev Immunol 4 249 258
143. AM Krieg H Wagner 2000 Causing a commotion in the blood: immunotherapy progresses from bacteria to bacterial DNA Immunol Today 21 521 526
144. C Zuany-Amorim J Hastewell C Walker 2002 Toll-like receptors as potential therapeutic targets for multiple diseases Nat Rev Drug Discov. 1 797 807
145. PS Creticos JT Schroeder RG Hamilton 2006 Immunotherapy with a ragweed-toll-like receptor 9 agonist vaccine for allergic rhinitis N Engl J Med 355 1445 1455
146. H2 cells by antigen-conjugated CpG oligodeoxynucleotides as a novel antigen-specific immunomodulator J Immunol 164 5575 5582
147. H Tighe K Takabayashi D Schwartz 2000 Conjugation of immunostimulatory DNA to the short ragweed allergen Amb a 1 enhances its immunogenicity and reduces its allergenicity J Allergy Clin Immunol. 106 124 134
148. MK Tulic PO Fiset P Christodoulopoulos 2004 Amb a 1-immunostimulatory oligodeoxynucleotide conjugate immunotherapy decreases the nasal inflammatory response J Allergy Clin Immunol. 113 235 241
149. Kerzl R, Mempel M, Ring J. Allergen-specific immunotherapy in food anaphylaxis. WAO J. (2008); 1:47-50.
150. L Mansfield 2006 Successful oral desensitization for systemic peanut allergy Ann Allergy Asthma Immunol 97 266 267
151. JJ Oppenheimer HS Nelson SA Bock F Christensen DY Leung 1992 Treatment of peanut allergy with rush immunotherapy J Allergy Clin Immunol. 90 256 262
152. G Patriarca E Nucera E Pollastrini 2006 Oral rush desensitization in peanut allergy: a case report Dig Dis Sci 51 471 473
153. B Bjorksten 1999 The intrauterine and post natal environments J Allergy Clin Immunol. 104 1119 1127
154. SH Arshad B Bateman A Sadeghnejad C Gant SM Matthews 2007 Prevention of allergic disease during childhood by allergen avoidance: the Isle of Wight prevention study J Allergy Clin Immunol. 119 307 313
155. SH Sicherer DY Leung 2008 Advances in allergic skin disease, anaphylaxis, and hypersensitivity reactions to foods, drugs, and insects in 2007 J Allergy Clin Immunol. 121 1351 1358
156. JG Wheeler SJ Shema ML Bogle 1997 Immune and clinical impact of Lactobacillus acidophilus on asthma Ann Allergy Asthma Immunol 79 229 233
157. T Helin S Haahtela T Haahtela 2002 No effect of oral treatment with an intestinal bacterial strain, Lactobacillus rhamnosus (ATCC 53103), on birch-pollen allergy: a placebo-controlled double-blind study Allergy 57 243 246
158. MF Wang HC Lin YY Wang CH Hsu 2004 Treatment of perennial allergic rhinitis with lactic acid bacteria Pediatr Allergy Immunol 15 152 158
159. YJ Guo D Wu KY Wang SH Sun 2007 Adjuvant effects of Bacillus Calmette-Guerin DNA or CpG-oligonucleotide in the immune response to Taenia solium cysticercosis vaccine in porcine Scand J Immunol 66 619 627
160. I Stelmach K Smejda J Jerzynska 2007 Decreased markers of atopy in children with presumed early exposure to allergens, unhygienic conditions, and infections Ann Allergy Asthma Immunol 99 170 177
161. PG Holt 1994 A potential vaccine strategy for asthma and allied atopic diseases during early childhood The Lancet. 344 456 458